Abbas El Sahili

Company: Singzyme

Job title: Chief Executive Officer

Seminars:

A Reliable & Flexible Technology for the Rapid Conjugation of Antibodies & Other Biologics 12:00 pm

• Discussing how Singzyme’s technology accelerates the development of cancer immunotherapy, allowing faster production of antibody-drug conjugates with minimal footprint on the final product and the possibility to attach two payloads with a defined DAR • Examining how this technology also allows imaging for disease diagnosis: production of radiopharmaceuticals for PET scan imaging (Nanobodies or…Read more

day: Scientific Program Day 1